Hormone Replacement Therapy Market is expected to grow to USD 22.31 billion in 2

Posted by rohan on March 15th, 2018

Through Hormone replacement therapy (HRT), a patient receives hormones, either to supplement a lack of naturally occurring hormones or to replace them with other hormones. Most of the hormone replacement therapies takes place for conditions like Menopause in woman (Estrogen Therapy). The Global Hormone Replacement Therapy Market is estimated at USD 15.75 billion in 2016 and is predicted to reach USD 22.31 billion by 2021, growing at a CAGR of 7.21%.

Nearly 80% of menopausal women experience mild symptoms. While a quarter have severe symptoms, of these only a small proportion of menopausal women currently take hormone replacement therapy. At present, combination of drugs is used to treat these conditions, which are known to have a better efficacy and safety parameter.

Browse market data tables and in-depth TOC of the Global Hormone Replacement Therapy Market to 2021 @ https://www.marketdataforecast.com/market-reports/global-hormone-replacement-therapy-market-957/

Increasing awareness on post-menopausal hazards, novel formulations, rise in unmet medical needs which require the employment of hormone therapy are the few factors driving the growth of global hormone replacement therapy market.

However, presence of side effects, such as bleeding, bloating, breast tenderness or enlargement, headaches, mood changes, and nausea, risk of breast cancer, heart disease, and stroke is restraining the growth of the market. Along with this, high cost of therapy is acting as a major hurdle. An average estrogen replacement therapy will cost $ 10,000 per annum to a patient. This is limiting its reach to middle class consumers, especially those of developing nations. Further, several researches shows that women with high susceptibility to coronary diseases should not go for hormone replacement therapy thereby decreasing the size of target audience.

Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/global-hormone-replacement-therapy-market-957/request-sample

The global hormone replacement therapy market is segmented on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. With a market share of more than 60%, the estrogen replacement therapy segment dominates the market. And on the basis of route of administration the market is classified as oral, parenteral, transdermal and other routes. The oral route of administration is regarded as one of the safest and most preferred routes of drug administration.

Further, on the basis of geography, the hormone replacement therapy market is analysed under regions namely, North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Moreover, under each region, major countries market values are provided.  North America dominated the market, where the majority of the contribution was from the USA. While, the market in the APAC region is expected to witness a rapid growth during the forecast period.

Some of the key players operating in the hormone replacement industry are Abbott Laboratories, Novartis, Pfizer, Mylan Laboratories, Amgen, Merck & Co., Bayer, Eli Lily, Novo Nordisk, Wyeth, F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co. Inc.

The scope of the report provides:

• The evaluation of the current market for your product or services and the future implications of the market
• Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
• Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
• Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
• The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
• The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
• Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
• Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
• Equip you with the information providing with the investment opportunities in the industry

Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206